- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04834583
Corona And Manual Professions (CAMP)
October 2, 2023 updated by: Iben Axen, Karolinska Institutet
COVID-19 Pandemic and Small Businesses in the Health Care Sector - Work Environment, Health and Economy of Swedish Chiropractors and Naprapaths
This observational study will follow the chiropractors and naprapaths in Sweden to study how work environment, health, and economy is changing during the COVID-19 pandemic.
Study Overview
Status
Completed
Conditions
Detailed Description
All manual therapists that are members of a professional organization in Sweden will be invited to participate. The study started in November 2020 with follow-ups planned after 3,6 and 12 months.
All data-collection is taking place with digital questionnaires.
There are three main areas of interest:
- Work environment (knowledge about viral contageon, protection, availability of protective measures, disturbances in care for patients)
- Health (physical and psychological, how many caught the virus?)
- Economy (income, costs, turnover)
Study Type
Observational
Enrollment (Actual)
703
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Stockholm, Sweden, 171 77
- Karolinska Institutet
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years to 65 years (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Sampling Method
Non-Probability Sample
Study Population
Manual therapists, clinically active in Sweden
Description
Inclusion Criteria:
- Chiropractor or naprapath working in Sweden
- clinically active
- belonging to a professional organization
Exclusion Criteria:
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Work environment
Time Frame: 12 months
|
Changes in routines according to the pandemic This includes systematic work environment routines, cleaning, wearing protective gear, not treating patients belonging to certain risk categories, changing appointment scheduling etc.
There are no validated questionnaires to examine these concepts, as we have not experienced a pandemic in modern times, so the questions are constructed by the research group.
|
12 months
|
Physical Health -Pain
Time Frame: 12 months
|
Physical pain using the Nordic Musculoskeletal Questionnaire
|
12 months
|
Psychological Health -depression
Time Frame: 12 months
|
Depression assessed with DASS-21
|
12 months
|
Psychological Health -sleep
Time Frame: 12 months
|
Sleep will be assessed using Karolinska Sleep Questionnaire.
|
12 months
|
Economy
Time Frame: 12 months
|
Changes in company turnover.
For clinic owners, this measure is assessing income and cost, estimated by clinic owners, There are no validated questionnaires to examine these concepts, as we have not experienced a pandemic in modern times, so the questions are constructed by the research group.
|
12 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Iben Axén, Karolinska Institutet
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 2, 2020
Primary Completion (Actual)
January 31, 2022
Study Completion (Actual)
April 30, 2023
Study Registration Dates
First Submitted
March 31, 2021
First Submitted That Met QC Criteria
April 6, 2021
First Posted (Actual)
April 8, 2021
Study Record Updates
Last Update Posted (Actual)
October 3, 2023
Last Update Submitted That Met QC Criteria
October 2, 2023
Last Verified
October 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- KIIMMRIAII
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Covid19
-
Anavasi DiagnosticsNot yet recruiting
-
Ain Shams UniversityRecruiting
-
Israel Institute for Biological Research (IIBR)Completed
-
Colgate PalmoliveCompleted
-
Christian von BuchwaldCompleted
-
Luye Pharma Group Ltd.Shandong Boan Biotechnology Co., LtdActive, not recruiting
-
University of ZurichLabor Speiz; Swiss Armed Forces; Universitätsspital ZürichEnrolling by invitation
-
Alexandria UniversityCompleted